{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:35:00Z","timestamp":1789756500583,"version":"4.0.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2007,4,12]],"date-time":"2007-04-12T00:00:00Z","timestamp":1176336000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2007,8,7]]},"DOI":"10.1007\/s10620-006-9665-4","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T11:02:42Z","timestamp":1176894162000},"page":"2433-2437","source":"Crossref","is-referenced-by-count":72,"title":["Corticosteroid-Responsive Cryptogenic Chronic Hepatitis: Evidence for Seronegative Autoimmune Hepatitis"],"prefix":"10.1007","volume":"52","author":[{"given":"Daniel J.","family":"Gassert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heriberto","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Reinus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,4,12]]},"reference":[{"issue":"40","key":"9665_CR1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","volume":"158","author":"GC Cook","year":"1971","unstructured":"Cook GC, Mulligan R, Sherlock S (1971) Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med 158(40):159\u2013185","journal-title":"Q J Med"},{"issue":"5","key":"9665_CR2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","volume":"63","author":"RD Soloway","year":"1972","unstructured":"Soloway RD, Summerskill WHJ, Baggenstoss AH, Geall MG, Gitnick GL, Elveback IR, Schoenfield LJ (1972) Clinical, biochemical and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 63(5):820\u2013833","journal-title":"Gastroenterology"},{"issue":"7806","key":"9665_CR3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","volume":"1","author":"IM Murray-Lyon","year":"1973","unstructured":"Murray-Lyon IM, Stern RB, Williams R (1973) Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet 1(7806):735\u2013737","journal-title":"Lancet"},{"issue":"3","key":"9665_CR4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0016-5085(83)90030-6","volume":"85","author":"AJ Czaja","year":"1983","unstructured":"Czaja AJ, Davis GL, Ludwig J, Baggenstoss AH, Taswell HF (1983) Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology. Gastroenterology 85(3):713\u2013717","journal-title":"Gastroenterology"},{"key":"9665_CR5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0025-6196(12)62106-5","volume":"65","author":"AJ Czaja","year":"1990","unstructured":"Czaja AJ, Hay JE, Rakela J (1990) Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis. Mayo Clin Proc 65:23\u201330","journal-title":"Mayo Clin Proc"},{"key":"9665_CR6","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/0016-5085(93)90656-W","volume":"104","author":"AJ Czaja","year":"1993","unstructured":"Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Homburger HA (1993) The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology 104:1755\u20131761","journal-title":"Gastroenterology"},{"key":"9665_CR7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0168-8278(98)80205-5","volume":"28","author":"S Kaymakoglu","year":"1998","unstructured":"Kaymakoglu S, Cakaloglu Y, Demir K, Turkoglu S, Badur S, Gurel S, Besisik F, Cevikbas U, Okten A (1998) Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis? J Hepatol 28:78\u201383","journal-title":"J Hepatol"},{"issue":"2","key":"9665_CR8","first-page":"300","volume":"91","author":"DL Thiele","year":"1996","unstructured":"Thiele DL, DuCharme L, Cunningham MR, Mimms LT, Cuthbert JA, Lee WM, Combes B (1996) Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients. Am J Gastroenterol 91(2):300\u2013308","journal-title":"Am J Gastroenterol"},{"key":"9665_CR9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","volume":"1","author":"M Manns","year":"1987","unstructured":"Manns M, Gerken G, Kyriatsoules A, Starlitz M, Meyer zum Buschenfelde KH (1987) Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against soluble liver antigen. Lancet 1:292\u2013294","journal-title":"Lancet"},{"key":"9665_CR10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, et\u00a0al. (1999) International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929\u2013938","journal-title":"J Hepatol"},{"key":"9665_CR11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199604043341406","volume":"334","author":"EL Krawitt","year":"1996","unstructured":"Krawitt EL (1996) Autoimmune hepatitis. N Engl J Med 334:897\u2013903","journal-title":"N Engl J Med"},{"issue":"2","key":"9665_CR12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","volume":"36","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Freese DK (2002) Diagnosis and treatment of autoimmune hepatitis. Hepatology 36(2):479\u2013497","journal-title":"Hepatology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-006-9665-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-006-9665-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-006-9665-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T12:25:32Z","timestamp":1587471932000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-006-9665-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,12]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,8,7]]}},"alternative-id":["9665"],"URL":"https:\/\/doi.org\/10.1007\/s10620-006-9665-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,12]]}}}